Japan approves Remdesivir to treat critically ill COVID-19 patients

Japan |  News | 0 Comment | 13 May, 2020

Gilead Sciences, Inc. has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has grante...Read more

Daiichi Sankyo gets BTD for potential gastric cancer drug

Japan |  News | 0 Comment | 13 May, 2020

Daiichi Sankyo Company, Limited and AstraZeneca’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted ...Read more

Hitachi opens First Europe based Proton Therapy system in Spain

Japan |  News | 0 Comment | 08 May, 2020

Hitachi, Ltd. on 8 May 2020 announced that it has provided its advanced proton therapy system to Clinica Universidad de ...Read more

CoVIg-19 plasma alliance building strong momentum

Japan |  News | 0 Comment | 08 May, 2020

The CoVIg-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the deve...Read more

Ajinomoto inks manufacturing agreement for COVID-19 drug

Japan |  News | 0 Comment | 07 May, 2020

Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing serviceswi...Read more

Harvard, Astellas establish strategic research alliance

Japan |  News | 0 Comment | 01 May, 2020

Harvard University and Japanese firm Astellas Pharma Inc. have established a three-year strategic research alliance to s...Read more

Astellas, Insilico Medicine bank on AI for drug discovery

Japan |  News | 0 Comment | 04 May, 2020

Hong Kong based Insilico Medicine has announced that it has entered into a research collaboration agreement with Ja...Read more

ProThera Bio, Takeda work towards treating acute inflammatory conditions

Japan |  News | 0 Comment | 29 Apr, 2020

US based ProThera Biologics, Inc. and Japan headquartered Takeda Pharmaceutical Company Limited have announced...Read more

Japan observes cross protection from COVID-19 by JEV

Japan |  News | 0 Comment | 30 Apr, 2020

A significant discrepancy in mortality among even geographically close regions could be explained by a cross protection ...Read more

Takeda inks deal worth $670M with Orifarm

Japan |  News | 0 Comment | 29 Apr, 2020

Japan based Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a p...Read more

Terumo donates $2.4 M for COVID-19 fight

Japan |  News | 0 Comment | 28 Apr, 2020

As the world joins together to support healthcare workers and others on the front lines providing critical care to patie...Read more

Astellas acquires Nanna Therapeutics for £12 M

Japan |  News | 0 Comment | 27 Apr, 2020

Japan based Astellas Pharma Inc. and UK based Nanna Therapeutics Limited have announced that Astellas has acquired Nanna...Read more

NEC designs blueprints for COVID-19 vaccines using AI

Japan |  News | 0 Comment | 24 Apr, 2020

Japan based NEC Corporation has announced analysis results from efforts using AI prediction platforms to design blueprin...Read more

Esperion & Otsuka to develop treatment for hypercholesterolemia

Japan |  News | 0 Comment | 23 Apr, 2020

US based Esperion has announced that the company has entered into a collaboration agreement with Otsuka Pharmaceutic...Read more

Daiichi Sankyo to donate $1M for COVID-19 relief fund

Japan |  News | 0 Comment | 17 Apr, 2020

Daiichi Sankyo Company, Limited has announced that, through the Japan Center for International Exchange, it will make a ...Read more

Fujifilm accelerates favipiravir production for COVID-19 treatment

Japan |  News | 0 Comment | 16 Apr, 2020

Fujifilm is ramping up production of its antiviral treatment drug favipiravir, one of many approved drugs being tested...Read more

Daiichi Sankyo commences gene therapy research to restore vision

Japan |  News | 0 Comment | 14 Apr, 2020

Japan based Daiichi Sankyo Company, Limited, Mitsubishi UFJ Capital Co., Ltd. and Nagoya Institute of Technology ha...Read more

Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy

Japan |  News | 0 Comment | 10 Apr, 2020

Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April ...Read more